Audit 53797

FY End
2022-06-30
Total Expended
$1.41B
Findings
14
Programs
483
Organization: University of Pennsylvania (PA)
Year: 2022 Accepted: 2023-03-19

Organization Exclusion Status:

Checking exclusion status...

Findings

ID Ref Severity Repeat Requirement
47195 2022-001 - Yes C
47196 2022-002 - - I
47197 2022-001 - Yes C
47198 2022-001 - Yes C
47199 2022-001 - Yes C
47200 2022-001 - Yes C
47201 2022-001 - Yes C
623637 2022-001 - Yes C
623638 2022-002 - - I
623639 2022-001 - Yes C
623640 2022-001 - Yes C
623641 2022-001 - Yes C
623642 2022-001 - Yes C
623643 2022-001 - Yes C

Programs

ALN Program Spent Major Findings
93.498 Provider Relief Fund $201.28M Yes 0
84.268 Federal Direct Loans $195.49M - 0
84.425F Covid-19 - Heerf Funding - Institutional $22.49M Yes 0
84.038 Perkins Loan Outstanding Loans Issued As July 1, 2021 $20.97M - 0
84.425E Covid-19 - Education Stabilization Fund $17.85M Yes 0
93.350 National Center for Advancing Translational Sciences $11.98M Yes 0
97.036 Disaster Grants - Public Assistance (presidentially Declared Disasters) $11.56M Yes 0
97.036 Covid -19 Disaster Grants - Public Assistance (presidentially Declared Disasters) $10.80M Yes 0
93.397 Cancer Centers Support Grants $10.77M Yes 1
93.342 Hpl Dental Outstanding As of 07/01/2021 $9.13M - 0
84.063 Federal Pell Grant Program $8.98M - 0
12.630 Basic, Applied, and Advanced Research in Science and Engineering $7.38M Yes 1
93.RD Niaid Centers of Excellence for Influenza Research and Response $7.16M Yes 1
93.RD Integrated Informatics Resources for Eukaryotic Microbial Pathogens An $5.84M Yes 0
93.847 Diabetes, Digestive, and Kidney Diseases Extramural Research $5.80M Yes 1
47.076 Education and Human Resources $5.37M Yes 0
93.855 Allergy and Infectious Diseases Research $4.70M Yes 0
47.041 Covid-19 - Engineering $4.35M Yes 1
93.866 Aging Research $3.79M Yes 0
21.027 Covid-19 - PA Act II Funding - American Rescue Act $3.66M - 0
47.049 Mathematical and Physical Sciences $3.58M Yes 0
93.077 Family Smoking Prevention and Tobacco Control Act Regulatory Research $3.53M Yes 0
84.007 Federal Supplemental Educational Opportunity Grants $3.34M - 0
47.041 Engineering $3.14M Yes 0
93.342 Hpl Dental Issued After 07/01/2021 $3.10M - 0
93.364 Nursing Student Loan Undergraduate Outstanding Loans Issued As of 07/01/2021 $3.07M - 0
93.113 Environmental Health $3.03M Yes 0
84.033 Federal Work-Study Program $2.93M - 0
93.859 Biomedical Research and Research Training $2.83M Yes 0
12.910 Research and Technology Development $2.80M Yes 1
93.342 Hpl Vet Outstanding As of 07/01/2021 $2.72M - 0
81.049 Office of Science Financial Assistance Program $2.50M Yes 0
93.242 Mental Health Research Grants $2.46M Yes 0
93.342 Lds Medical Outstanding As of 07/01/2021 $2.39M - 0
93.353 21st Century Cures Act - Beau Biden Cancer Moonshot $2.34M Yes 0
93.264 Nurse Faculty Loan Program Outstanding As of 07/01/21 $2.23M - 0
93.279 Drug Abuse and Addiction Research Programs $2.04M Yes 0
12.RD Restoring Memory with Task-Independent Semi-Chronic Closed-Loop Direct $1.90M Yes 0
93.461 Covid-19 Testing for the Uninsured $1.86M Yes 0
93.RD Civics Component A $1.78M Yes 0
93.395 Cancer Treatment Research $1.70M Yes 0
93.172 Human Genome Research $1.67M Yes 0
12.RD Cairo-Ms: Conflicting Account Information Resources in Omnivorous Medi $1.63M Yes 0
93.838 Lung Diseases Research $1.58M Yes 0
93.865 Child Health and Human Development Extramural Research $1.56M Yes 0
93.RD Inhalation Toxicology of Chlorine Gas-on-A-Chip $1.55M Yes 0
93.393 Cancer Cause and Prevention Research $1.53M Yes 0
12.431 Basic Scientific Research $1.38M Yes 0
12.300 Basic and Applied Scientific Research $1.35M Yes 0
93.273 Alcohol Research Programs $1.34M Yes 0
93.310 Trans-Nih Research Support $1.27M Yes 0
93.RD Preclinical Vector Production Core Laboratory $1.26M Yes 0
12.RD Corpora of Annotated Events Represented Under Schemas (caerus) $1.24M Yes 0
93.505 Affordable Care Act (aca) Maternal, Infant and Early Childhood Home Visiting Program $1.13M - 0
12.420 Military Medical Research and Development $1.10M Yes 0
93.121 Oral Diseases and Disorders Research $1.10M Yes 0
93.855 Covid-19 - Allergy and Infectious Diseases Research $1.08M Yes 0
93.310 Covid-19 - Trans-Nih Research Support $1.08M Yes 0
93.233 National Center on Sleep Disorders Research $1.05M Yes 0
93.351 Research Infrastructure Programs $1.04M Yes 0
12.RD Integrated Static and Dynamic Approaches to High-Assurance for Learnin $1.03M Yes 0
93.867 Vision Research $1.03M Yes 0
93.286 Discovery and Applied Research for Technological Innovations to Improve Human Health $1.01M Yes 0
93.838 Covid-19 - Lung Diseases Research $1.01M Yes 0
93.396 Cancer Biology Research $976,273 Yes 0
93.135 Centers for Research and Demonstration for Health Promotion and Disease Prevention $972,345 Yes 0
93.136 Injury Prevention and Control Research and State and Community Based Programs $945,463 Yes 0
19.021 Investing in People in the Middle East and North Africa $895,620 Yes 0
93.307 Minority Health and Health Disparities Research $887,745 Yes 0
93.361 Nursing Research $848,955 Yes 0
93.173 Research Related to Deafness and Communication Disorders $790,774 Yes 0
84.305 Education Research, Development and Dissemination $783,353 Yes 0
93.RD Assessment of the Efficacy of Acute Pain Treatments: An Rtc Re-Analysi $782,251 Yes 0
93.846 Arthritis, Musculoskeletal and Skin Diseases Research $770,493 Yes 0
93.RD A Scalable, Patient-Centered Approach for "right-Sizing" Opioid Prescr $759,186 Yes 0
93.394 Cancer Detection and Diagnosis Research $753,702 Yes 0
93.399 Cancer Control $741,196 Yes 0
93.364 Nursing Student Loan Undergraduate New Loans Issued During 2022 $740,390 - 0
10.561 State Administrative Matching Grants for the Supplemental Nutrition Assistance Program $740,217 - 0
93.840 Translation and Implementation Science Research for Heart, Lung, Blood Diseases, and Sleep Disorders $725,738 Yes 0
20.RD National Sleep Study Technical Support $722,320 Yes 0
93.350 Covid-19 - National Center for Advancing Translational Sciences $696,960 Yes 0
93.342 Hpl Vet Issued After 07/01/2021 $695,500 - 0
93.RD Covid-19 - Whole-Genome Sequencing to Define Sars-Cov-2 Variant Populations Durin $682,127 Yes 0
12.RD Multiferroic Vector Magnetometer (mfvm) $677,864 Yes 0
93.879 Medical Library Assistance $674,225 Yes 0
93.226 Research on Healthcare Costs, Quality and Outcomes $664,400 Yes 0
93.398 Cancer Research Manpower $661,573 Yes 0
93.242 Covid-19 - Mental Health Research Grants $648,967 Yes 0
47.074 Biological Sciences $644,224 Yes 0
97.036 Covid-19 Disaster Grants - Public Assistance (presidentially Declared Disasters) $627,638 Yes 0
84.047 Trio Upward Bound $626,431 - 0
93.837 Covid-19 - Cardiovascular Diseases Research $622,645 Yes 0
93.837 Cardiovascular Diseases Research $617,352 Yes 0
12.910 Covid-19 - Research and Technology Development $594,721 Yes 0
93.011 Covid-19 - National Organizations of State and Local Officials $590,542 Yes 0
14.231 Emergency Soulutions Grant Progoram $588,689 - 0
84.015 National Resource Centers Program for Foreign Language and Area Studies Or Foreign Language and International Studies Program and Foreign Language and Area Studies Fellowship Program $582,720 - 0
12.RD Starkpepper $573,081 Yes 0
14.267 Continuum of Care Program $563,134 - 0
93.225 National Research Service Awards Health Services Research Training $552,321 Yes 0
93.884 Grants for Primary Care Training and Enhancement $531,286 Yes 0
93.839 Covid-19 - Blood Diseases and Resources Research $528,202 Yes 0
43.003 Exploration $525,457 Yes 0
12.RD Better Extraction From Text Towards Enhanced Retrieval (better) $513,461 Yes 0
20.701 University Transportation Centers Program $493,153 Yes 0
93.084 Covid-19 - Prevention of Disease, Disability, and Death by Infectious Diseases $474,097 Yes 0
81.RD Research for Atlas Experiment $467,105 Yes 0
93.117 Preventive Medicine Residency $458,134 Yes 0
93.173 Covid-19 - Research Related to Deafness and Communication Disorders $453,141 Yes 0
12.351 Scientific Research - Combating Weapons of Mass Destruction $449,233 Yes 0
84.287 Twenty-First Century Community Learning Centers $447,349 - 0
84.027 Special Education Grants to States $446,756 - 0
93.264 Nurse Faculty Loan Program Issued During Fy22 $432,709 - 0
16.738 Edward Byrne Memorial Justice Assistance Grant Program $425,469 - 0
16.560 National Institute of Justice Research, Evaluation, and Development Project Grants $416,055 Yes 0
93.364 Nursing Student Loan Graduate Outstanding Loans Issued As of 07/01/2021 $411,918 - 0
93.RD Spore in Skin Cancer (project 1) $400,386 Yes 0
16.746 Capital Case Litigation Initiative $393,300 Yes 0
19.025 U.s. Ambassadors Fund for Cultural Preservation $386,773 - 0
93.RD An Implantable Wireless Tactile Feedback System $382,780 Yes 0
12.RD Scutle (sociocultural Understanding Through Linguistic Expression) $382,669 Yes 0
94.006 Americorps $370,396 - 0
12.RD Robust Autonomy in Uavs on A Convergent Digital-Analog Ferroelectronic $366,605 Yes 0
47.070 Computer and Information Science and Engineering $349,474 Yes 0
93.266 Health Systems Strengthening and Hiv/aids Prevention, Care and Treatment Under the President's Emergency Plan for Aids Relief $346,228 Yes 0
93.732 Mental and Behavioral Health Education and Training Grants $345,378 Yes 0
43.007 Space Operations $344,110 Yes 0
93.918 Grants to Provide Outpatient Early Intervention Services with Respect to Hiv Disease $340,168 - 0
93.243 Substance Abuse and Mental Health Services Projects of Regional and National Significance $338,056 - 0
93.945 Assistance Programs for Chronic Disease Prevention and Control $336,310 Yes 0
93.RD Quantitative Analysis of Longitudinal Mr Images in Blsa Participants $335,045 Yes 0
93.989 International Research and Research Training $327,872 Yes 0
93.RD Regulation of Axon Guidance Receptor Trafficking in the Developing Mam $326,790 Yes 0
43.001 Science $322,362 Yes 0
12.800 Air Force Defense Research Sciences Program $321,247 Yes 0
93.575 Covid-19 - Child Care and Development Block Grant $313,373 - 0
12.RD Behavioral Characterization of Odor Detection Dogs for Selection of PO $313,245 Yes 0
93.686 Hrsa Ehe-A Plan for America $311,458 - 0
43.001 Covid-19 - Science $306,232 Yes 0
93.RD Clinical and Molecular Determinants of Transmission of Esbls in the CO $306,171 Yes 0
12.RD Dod Phase II Sttr 12.a, Topic No. A12a-T009 $303,064 Yes 0
93.RD Continued Assessment of the Efficacy of Chronic Opioid Pain Treatments $301,418 Yes 0
93.059 Training in General, Pediatric, and Public Health Dentistry $300,503 - 0
93.788 Ddap - Support for Pregnant Woman with Oud $300,000 - 0
93.575 Child Care and Development Block Grant $295,949 - 0
93.865 Covid-19 - Child Health and Human Development Extramural Research $292,926 Yes 0
47.075 Social, Behavioral, and Economic Sciences $286,204 Yes 0
93.307 Covid-19 - Minority Health and Health Disparities Research $282,343 Yes 0
93.847 Covid-19 - Diabetes, Digestive, and Kidney Diseases Extramural Research $281,129 Yes 0
93.994 Maternal and Child Health Services Block Grant to the States $280,166 Yes 0
64.RD Va Merit Award: Immune and Genetic Controls of Tissue Regeneration in $275,085 Yes 0
93.RD Covid-19 - Medical Imaging and Data Consortium: Rapid Response to Covid-19 Pandem $266,317 Yes 0
12.RD Task-And-User Aware Representation Learning for Fine Grained Crossling $263,159 Yes 0
93.RD Spore in Skin Cancer (core B) $263,049 Yes 0
84.042 Trio Student Support Services $258,494 - 0
12.RD Circulating Cfdna Fragments for the Detection and Diagnosis of Traumat $257,481 Yes 0
81.RD Tailoring Photophysical Energy Transfer for Selective Separations of C $256,765 Yes 0
94.013 Volunteers in Service to America $252,281 - 0
16.582 Crime Vicitim Assistance/discretionary Grants $246,166 - 0
12.RD Development of Ai Tools for Antibiotic Discovery $241,400 Yes 0
12.RD Systemic Generative Engineering $239,508 Yes 0
93.914 Part A Rw Hiv/aids Minority Aids Initiative $238,802 - 0
93.213 Research and Training in Complementary and Integrative Health $233,183 Yes 0
12.RD Energy-Efficient Vision-Based Navigation Through Event-Based Sensing A $229,950 Yes 0
93.342 Lds Medical Issud After 07/01/2021 $229,169 - 0
47.079 Office of International Science and Engineering $225,296 Yes 0
93.914 Hiv Emergency Relief Project Grants $225,250 - 0
93.RD Ceirs Option 12 (2018-19) $222,553 Yes 0
93.RD Evidence-Based Practice Centers - Ahrq Epc Vi Idiq Contract $222,482 Yes 0
68.RD National Gallery of Art Extension Service $217,402 Yes 0
64.RD Bioactive Injectable Implants for Functional Interverterbral Disc Rege $215,461 Yes 0
93.877 Autism Collaboration, Accountability, Research, Education, and Support $212,326 Yes 0
43.002 Aeronautics $210,036 Yes 0
84.044 Trio Talent Search $209,358 - 0
47.050 Geosciences $209,082 Yes 0
64.RD Knee Joint Resurfacing with Anatomic Tissue Engineered Osteochondral I $208,214 Yes 0
12.RD Hypothesis-Guided Model Revision Over Multiple Aligned Representations $206,393 Yes 0
93.958 Block Grants for Community Mental Health Services $205,507 - 0
93.435 Innovative State and Local Public Health Strategies to Prevent and Manage Diabetes and Heart Disease and Stroke- $205,187 Yes 0
93.879 Covid-19 - Medical Library Assistance $205,001 Yes 0
64.RD Development of A Unique in Vitro Test Bed Model to Explore Mechanisms $203,813 Yes 0
93.914 Hiv Emergency Relief Projects Grants $203,020 - 0
12.RD Top Gated 2d/alscn/sic Structures for Surface Acoustic Wave Amplifiers $200,959 Yes 0
12.RD Cross-Domain Transfer Learning $197,965 Yes 0
81.086 Conservation Research and Development $191,837 Yes 0
93.364 Nursing Student Loan Graduate Outstanding New Loans Issued During 2022 $189,400 - 0
10.310 Agriculture and Food Research Initiative (afri) $188,954 Yes 0
93.RD Clinical Evaluation of Nestorone (nes) and Testosterone (t) Combinatio $182,832 Yes 0
10.310 Covid-19 - Agriculture and Food Research Initiative (afri) $178,069 Yes 0
81.135 Advanced Research Projects Agency - Energy $172,702 Yes 0
93.047 American Indian Chronic Renal Insufficiency Cohort Study Ai-Cric $171,453 Yes 0
81.RD Hybrid Quantum/classical Algorithms for Photochemistry and Nonadiabati $168,161 Yes 0
93.778 Ids Base Unitary $165,535 - 0
93.RD Investigating Multidrug Resistance Prevalence in Botswana - Assessing $161,459 Yes 0
93.318 Covid-19 - Protecting and Improving Health Globally: Building and Strengthening Public Health Impact, Systems, Capacity and Security $161,204 Yes 0
93.667 Social Services Block Grant $156,186 - 0
93.RD Promoting and Supporting Innovation in Tanf Data $155,325 Yes 0
12.RD Focus - Forecasting Counterfactuals in Uncontrolled Settings $155,066 Yes 0
20.200 Highway Research and Development Program $154,492 Yes 0
12.RD Self-Reconfigurable Modular Ground Robots $150,799 Yes 0
93.262 Occupational Safety and Health Program $147,039 Yes 0
12.RD Thermionic Power Generation for Individual Soldier $144,759 Yes 0
93.342 Hpl Medical Outstanding As of 07/01/2021 $142,177 - 0
81.RD Center for 3d Ferroelectric Microelectronics $138,094 Yes 0
16.838 Victims of Crime Act (voca) - Lancaster County Partnership for Prevention - Opioid Misuse $136,468 - 0
93.788 Opioid Str $134,355 - 0
12.RD Electromechanical Components for Efficient, Small Scale Power Conversi $129,257 Yes 0
93.RD Ceirs Option 16c Ea "h5h7" (2018-20) $128,064 Yes 0
64.RD Chronic Focal and Diffuse Traumatic Brain Injury: Mechanisms Underlyin $123,345 Yes 0
64.RD Tissue Engineered Total Disc Replacement in A Large Animal Model $121,642 Yes 0
84.021 Overseas Programs - Group Projects Abroad $118,484 - 0
93.916 Federal Tuberculosis Control $116,788 - 0
16.609 Project Safe Neighborhoods $112,753 Yes 0
93.RD Covid-19 - Secondary Infections and Antibiotic Resistance in Post-Acute Care Pati $111,928 Yes 0
93.RD Covid-19 - Rapid Validation and Behavioral Economics to Increase Enrollment and E $111,204 Yes 0
64.RD Transplantable Micro-Tissue Engineered Neural Networks to Restore the $110,784 Yes 0
12.RD Secure Handling of Isolated Executables Without Leaking (closure). $109,032 Yes 0
81.RD High Performance Electromechanical Filters Realized in Highly Doped Al $108,465 Yes 0
43.RD Foam Optics and Mechanics $107,977 Yes 0
93.839 Blood Diseases and Resources Research $107,149 Yes 0
93.RD Developing Assays to Characterize Antibodies Elicited by New Universal $106,269 Yes 0
93.788 Lanc Co. Prevention Partnership Continuation $105,520 - 0
12.RD Post-Cmos Compatible Aluminum Scandium Nitride Ferroelectric Field Eff $105,143 Yes 0
93.RD Option 23: Multivalent Influenza Mrna Vaccines $102,753 Yes 0
10.025 Plant and Animal Disease, Pest Control, and Animal Care $102,506 Yes 0
12.RD Designer Optical Superlatices From Excitron Materials $101,450 Yes 0
64.RD Covid-19 - Covid-19: Understanding the Role of Corona Virus Induced Disruption of $101,008 Yes 0
10.001 Agricultural Research Basic and Applied Research $100,821 Yes 0
47.076 Covid-19 - Education and Human Resources $100,808 Yes 0
93.RD Rapid Point of Care Molecular Diagnostics of Hcv $100,432 Yes 0
64.RD Sdr: Genomic Analysis of Blast Tube Induced Tbi in Mice $100,247 Yes 0
64.RD Va Ipa-Aneeza Agha $99,963 Yes 0
84.324 Research in Special Education $98,610 Yes 0
93.914 Care Services Case Management $98,251 - 0
93.RD Development of A Prototype Software for Automated Pet/ct Interpretatio $97,706 Yes 0
93.RD Efficacy and Mechanisms of Virtual Reality Treatment of Phantom Leg PA $96,286 Yes 0
93.940 Hiv Emergency Relief Project Grants $95,865 - 0
93.RD Deep Phenotyping of Angptl3, Angptl4 and Angptl8 Human Knockouts and P $95,326 Yes 0
12.RD Linking Investigations in Trauma and Emergency Services (lites) $94,925 Yes 0
45.301 Museums for America $94,839 - 0
93.914 Ryan White Part A Care Services-Aaco $94,045 - 0
64.RD Preferences Elicited and Respected for Seriously Ill Veterans Through $93,376 Yes 0
81.RD Multi-Source Learning-Accelerated Design of High-Efficiency Multi-Stag $92,520 Yes 0
81.RD Pipeline Infrastructure Operations Personnel Effort for the Lsst Dark $91,904 Yes 0
93.RD Covid-19 - A Multicenter, Adaptive, Randomized Blinded Controlled Trial of the Sa $91,245 Yes 0
19.040 Public Diplomacy Programs $90,000 - 0
93.243 Substance Abuse and Mental Health Services Administration (samhsa) - First Responders - Comprehensive Naloxone Distribution and Recovery Service Initiative $88,582 - 0
12.RD Hr001121s0007-08 : Third-Party Verification of Cots Software Complianc $85,481 Yes 0
84.367 Supporting Effective Instruction State Grants (formerly Improving Teacher Quality State Grants) $84,951 - 0
64.RD Group (project Life Force) Vs. Individual Suicide Safety Planning Rc $84,662 Yes 0
12.400 Military Construction, National Guard $84,523 Yes 0
12.RD Collective Lifelong Learning by Distributed Agents $84,508 Yes 0
12.U01 Darpa Ipa #0246 J.m. Smith $83,443 - 0
16.575 Victims of Crime Act (voca) - Lancaster County Child Victims Program Enhancement $83,282 - 0
64.RD Covid-19 - Covid-19: Elucidating the Role of the Nasal Epithelium in Sars-Cov-2 I $82,714 Yes 0
93.103 Food and Drug Administration Research $80,641 Yes 0
45.024 Promotion of the Arts Grants to Organizations and Individuals $79,163 - 0
43.012 Space Technology $78,967 Yes 0
81.089 Fossil Energy Research and Development $78,448 Yes 0
12.RD Aluminum Scandium Nitride Mems Pdk $76,452 Yes 0
81.RD Wfirst Science Investigation Teams and Adjutant Scientists $76,052 Yes 0
93.217 Family Planning Service $75,812 - 0
93.918 Rw Part C Hiv Early Prevention $75,000 - 0
64.RD Phenotypic and Genomic Architecture of Cardiovascular Disease Subtypes $74,438 Yes 0
11.609 Measurement and Engineering Research and Standards $73,684 Yes 0
93.RD Mechanical Device for the Prevention of Vte in High Risk Patient Popul $73,218 Yes 0
64.RD Tissue Engineered Nigrostriatal Pathway As A Testbed for Evaluating Ax $73,132 Yes 0
64.RD Ipa $72,919 Yes 0
93.RD Bacterial Interference to Prevent Staphylococcus Aureus Infection $70,956 Yes 0
93.853 Covid-19 - Extramural Research Programs in the Neurosciences and Neurological Disorders $69,608 Yes 0
93.914 Mental Health Services $68,524 - 0
12.RD Bio-Fabricated Nerve-Muscle Complexes to Augment Regeneration and Faci $68,410 Yes 0
93.421 Covid-19 - Strengthening Public Health Systems and Services Through National Partnerships to Improve and Protect the Nations Health $68,358 Yes 0
81.RD Design of A Target and Dichroicon for Photon Sorting at Chess $67,520 Yes 0
93.110 Maternal and Child Health Federal Consolidated Programs $66,631 - 0
93.084 Prevention of Disease, Disability, and Death by Infectious Diseases $66,101 Yes 0
11.619 Arrangements for Interdisciplinary Research Infrastructure $65,704 Yes 0
14.218 Community Development Block Grants/entitlement Grants $64,080 - 0
16.RD Evaluation of the Police Assisted Diversion Pilot in Philadelphia $62,787 Yes 0
93.RD Covid-19 - the Impact of Sars-Cov-2 Infection During Pregnancy on Obstetric and N $62,760 Yes 0
64.RD The Role of Functional Iron Deficiency in Systemic Complications of Ck $61,561 Yes 0
64.RD Beers - Va Merit Award $61,472 Yes 0
47.RD Harnessing Evolution to Reveal the Molecular Logic of Kinetochore Wiri $61,162 Yes 0
84.022 Overseas Programs - Doctoral Dissertation Research Abroad $60,641 Yes 0
94.U04 Next Steps Americorps 2020/2021 $58,615 - 0
19.345 International Programs to Support Democracy, Human Rights and Labor $57,126 Yes 0
93.919 Cooperative Agreements for State-Based Comprehensive Breast and Cervical Cancer Early Detection Programs $55,739 - 0
47.075 Covid-19 - Social, Behavioral, and Economic Sciences $55,695 Yes 0
64.RD Problem Solving Therapy Program Ipa: Gregory Brown and Kelly Green $55,159 Yes 0
64.RD Pathologic Signaling Pathways in Aml Cells $54,166 Yes 0
64.RD Neuromodulation As A Therapy for Ptsd Following Chronic Tbi $53,766 Yes 0
64.RD Va Ipa: Randy Hastings (community Health Worker Project) $52,652 Yes 0
64.RD Va Ipa: Anthony Davis (community Health Worker Project) $52,652 Yes 0
84.334 Gaining Early Awareness and Readiness for Undergraduate Programs $51,666 - 0
81.RD Deep Underground Neutrino Experiment (dune) $51,569 Yes 0
15.945 Cooperative Research and Training Programs Resources of the National Park System $51,272 Yes 0
15.676 Youth Engagement, Education, and Employment $50,756 - 0
81.RD Watchman Pdr Effort $50,459 Yes 0
93.669 Child Abuse and Neglect State Grants $49,975 - 0
47.040 Cif: Small: Collaborative Research: Communications in Ultra-Low-Rate R $49,772 Yes 0
93.286 Covid-19 - Discovery and Applied Research for Technological Innovations to Improve Human Health $48,663 Yes 0
12.RD Transforming Research and Clinical Knowledge in Traumatic Brain Injury $48,068 Yes 0
93.RD Ipa Assignment Agreement $47,060 Yes 0
93.279 Covid-19 - Drug Abuse and Addiction Research Programs $46,421 Yes 0
64.RD Va Ipa: Lauraellen Ashcraft $46,219 Yes 0
93.RD Covid-19 - Maternal 'omics to Maximize Immunity $45,150 Yes 0
93.RD S. Aureus Strain-Level Diversity in Diabetic Wound Neutrophil Phenotyp $44,986 Yes 0
64.RD Immunologic Mechanisms for Heterogeneity of Cutaneous Lupus Erythemato $44,695 Yes 0
64.RD Neural Processing of Multisensory Speech at Millisecond and Millimeter $44,558 Yes 0
64.RD Queri Sage Ipa $43,546 Yes 0
64.RD Ipa Agreement for Melissa Naschek $43,153 Yes 0
12.RD Liquid-Fuel Thermionic Battlefield Generators $41,733 Yes 0
64.RD Va Ipa: Denerale Jones (community Health Worker Project) $41,012 Yes 0
17.259 Wioa Youth Activities $40,145 - 0
64.U16 Va/ipa Agreements for Mary Valiga, James Keith and Xiaowang Qu $38,702 - 0
93.914 Outpatient/ambulatory Medical Care $38,251 - 0
12.RD Contour Based Image Segmentation Sttr Phase II $37,846 Yes 0
64.RD Ipa - Statins and Cirrhosis: Reducing Events of Decompensation (sacred $37,686 Yes 0
84.184 School Safety National Activities (formerly, Safe and Drug-Free Schools and Communities-National Programs) $37,098 Yes 0
10.207 Animal Health and Disease Research $37,082 Yes 0
93.U08 Ipa Assignment Agreement $36,927 - 0
64.RD Covid-19 - Tammy Xu Fy22 Covid Ipa $36,439 Yes 0
93.RD Upcc08421: Phase II Multi-Center Trial of Anti-B Cell Maturation Antig $36,133 Yes 0
47.RD Mustang 2 Operations on the Green Bank Telescope $36,019 Yes 0
93.RD Population Health Research Support - Study of Pregnancy and Neonatal H $35,871 Yes 0
47.RD Sbir Phase Ii: Single Wearable Patch for Cost-Effective, Reliable, and $35,421 Yes 0
93.RD Upcc35419: Clinical Transplant-Related Long-Term Outcomes of Alternati $34,670 Yes 0
64.RD Va Ipa Baofeng Hu & Vu Nguyen - Va Merit $34,342 Yes 0
81.RD Non-Proliferation Anti-Neutrino Research $34,307 Yes 0
64.RD Va Comprehensive End-of-Life Care's Promise Center $34,170 Yes 0
81.RD In Operando Evaluation of Catalyst Morphology and Activity Under Co2 R $33,724 Yes 0
45.161 Promotion of the Humanities Research $33,442 Yes 0
47.070 Covid-19 - Computer and Information Science and Engineering $33,256 Yes 0
47.RD Ipa Agreement - Program Director in the Robust Intelligence Program $33,149 Yes 0
64.RD Ipa for K. Linn and J. Yan $32,370 Yes 0
93.103 Covid-19 - Food and Drug Administration Research $32,217 Yes 0
64.RD Optimization of Engineered Endplates to Improve in Vivo Integration of $32,211 Yes 0
64.RD Evidence Based Psychotherapy Program $32,134 Yes 0
64.RD Pathogenesis of Chronic Rhinosinusitis $31,819 Yes 0
93.RD Covid-19 - Mfmu Maternal Morbidity and Mortality During the Covid-19 Pandemic $31,502 Yes 0
64.RD Ipa Agreements for Alex Burdzy and Patrik Garren $31,351 Yes 0
93.391 Cdc Partner Crisis Response; Community Based Health Disparities $30,370 - 0
64.RD Year 1 Ipas for Mauck/burdick Va Spire Project: "hydrogel Delivery of $30,189 Yes 0
45.U05 Aia-Neh Lagash Archaeological Project: Second Season of Excavation $30,000 - 0
16.758 Ojjdp Passed Through National Children's Alliance $29,959 - 0
45.312 National Leadership Grants $29,710 - 0
64.RD Ipa for Saewhan Park - Racial Bias in A Va Algorithm for High-Risk Vet $29,666 Yes 0
64.RD Cognitive Behavioral Therapy (cbt-I) Augmentation of Topiramate in Pro $29,361 Yes 0
93.080 Blood Disorder Program: Prevention, Surveillance, and Research $29,316 Yes 0
64.RD The Role of Disc Nutrition in the Etiology and Clinical Treatment of D $28,161 Yes 0
64.RD Va Ipa: Jingyi Wu (racial and Ethnic Differences in Presentation and Q $27,914 Yes 0
64.U20 Cognitive Behavioral Therapy (cbt-I) Augmentation of Topiramate in Pro $27,503 - 0
64.RD Translational Modeling of Brain Injury Rehabilitation to Maximize Reco $27,454 Yes 0
93.RD Treatment for Mixed Urinary Incontinence: Mid-Urethral Sling Vs. Botox $27,374 Yes 0
64.RD Lynch Prime Ipa $25,886 Yes 0
64.RD Va Ipa Agreement for Sofia Lizza $25,609 Yes 0
93.RD Ceirs Option 16c Ea "ht" (2018-20) $25,222 Yes 0
47.RD Giving Credit Where Credit Is Due: Causal Impacts of Reverse Transfer $25,000 Yes 0
64.RD Ipa for Nayeli Nunez Cruz on "cognitive Behavioral Therapy for Insomni $24,842 Yes 0
45.RD Alisa Mellon Bruce Senior Fellow at the Center for Advanced Study in T $24,600 Yes 0
64.RD Caleigh Doherty Va Spire Ipa $24,521 Yes 0
64.RD Designing Neuronal Tissue Constructs That Mimic Brain-Specific Archite $24,195 Yes 0
64.RD Ipa - Holly Barilla to Deliver Cbt for Insomnia in Patients with Serio $24,091 Yes 0
64.RD Ipa #1, Chang-Mvp (m. Vujkovic)no Restricts Non-U.s. Entity Participat $23,975 Yes 0
12.RD Artcat: Autonomic Response to Disruptive Cyber-Attacks $23,801 Yes 0
64.RD Va Ipa: Molly Knowles (community Health Worker Project) $23,752 Yes 0
16.575 Victims of Crime Act (voca) - Lancaster County Child Victims Continuity of Care $23,678 - 0
20.614 National Highway Traffic Safety Administration (nhtsa) Discretionary Safety Grants and Cooperative Agreements $23,345 Yes 0
81.RD Advanced Instrumentation Testbed-Neutrino Experiment One (ait-Neo) $23,229 Yes 0
64.RD Precision Cardio-Metabolic Phenotyping for Genetic Discovery and Risk $22,850 Yes 0
93.186 National Research Service Award in Primary Care Medicine $22,659 Yes 0
93.224 Health Center Program (community Health Centers, Migrant Health Centers, Health Care for the Homeless, and Public Housing Primary Care) $22,460 - 0
12.420 Clott Study $22,326 Yes 0
64.RD Covid-19 - Caleigh Doherty Csp Va Ipa $22,129 Yes 0
64.RD Va Ipa Agreement for Richard Mason $22,039 Yes 0
64.RD Mechano-Active Annular Repair Device for Treating Disc Herniation $21,784 Yes 0
93.RD Covid-19 - Building Covid-19 Vaccine Confidence Among Nursing Students, Nurses, A $20,612 Yes 0
64.RD Ipa - Richard Crist (gamma) $20,330 Yes 0
64.RD Living Electrodes for Auditory Rehabilitation $19,635 Yes 0
64.RD Ipa Agreement for Daniel Traum $19,063 Yes 0
64.RD Covid-19 - Lea Williams Covid-19 Ipa $18,949 Yes 0
12.RD Automated Rapid Certification of Software (arcos) - Argument Comprehen $18,933 Yes 0
64.RD Va Ipa: Jingyi Wu (cardiovascular Care and Outcomes for Veterans Exper $18,609 Yes 0
93.321 Dietary Supplement Research Program $18,571 Yes 0
84.200 Graduate Assistance in Areas of National Need $18,428 - 0
64.RD Ipa for Mary Valiga - Million Veteran Program (mvp) $18,166 Yes 0
81.RD Itk Strips Assembly and Testing $18,081 Yes 0
64.RD Ipa Kember-Mvp004 $17,963 Yes 0
93.RD Covid-19 - Rapid and Ultra-Sensitive Sars-Cov-2 Antigen Detection for Acute Infec $17,810 Yes 0
47.RD Multiplexed Crispr Editing of T Cells Through Large Cargo Delivery Via $17,600 Yes 0
45.169 Promotion of the Humanities Office of Digital Humanities $17,474 - 0
93.866 Covid-19 - Aging Research $17,123 Yes 0
93.RD Evaluate the Safety and Quality of A 3d Printed, Single-Use Bioreactor $16,947 Yes 0
81.RD Deep Underground Neutrino Experiment (dune) - Daphne $15,710 Yes 0
93.RD Clinical Evaluation of Novel Products for Female Contraception (main S $15,034 Yes 0
93.RD Pk and Safety of Commonly Used Drugs in Lactating Women and Breastfed $15,008 Yes 0
64.RD Ipa Lynch Mirecc $14,798 Yes 0
64.RD Resurfacing of the Thumb Joint with A Biologic Tissue Engineered Impla $14,750 Yes 0
93.243 Mh Base Unitary $14,580 - 0
64.RD Va Ipa: Phoebe Whiteside (va Queri Grant) $14,398 Yes 0
93.RD Task Order 1 - Contraceptive Development Program Nichd Contraceptive C $14,304 Yes 0
12.RD Solution-Based Receptors for Large Surface Opioids Contamination Ident $14,298 Yes 0
93.361 Covid-19 - Nursing Research $14,148 Yes 0
42.U18 Using Primary Sources to Support Civically Engaged Argument Writing in $13,905 - 0
64.U17 Va Ipa for Kevin Lynch $13,626 - 0
64.U13 Cognitive Behavioral Therapy (cbt-I) Augmentation of Topiramate in Pro $13,334 - 0
93.RD Drcr Retina Network - Protocol Af $13,281 Yes 0
45.025 Promotion of the Arts Partnership Agreements $13,000 - 0
64.RD Ipa-Shimrit Keddem (project: Sage) $12,986 Yes 0
42.RD Updating Measures of Low-Value Care in Medicare $12,677 Yes 0
64.RD Va Ipa: Catherine Chadwick (community Health Worker Project) $12,615 Yes 0
64.U09 Va Ipa for Kevin Lynch $12,474 - 0
93.RD Instructor Led Training on Pharmacoepidemiology $12,450 Yes 0
93.RD Activity in Women at Risk for Early Delivery (aware). An Ancillary Stu $12,257 Yes 0
64.RD Tammy Xu Ipa $12,146 Yes 0
64.RD Va Ipa for Daniel Traum $12,002 Yes 0
64.RD Vujkovic Ipa #2 Year 2 $11,924 Yes 0
20.215 Highway Training and Education $11,667 Yes 0
64.RD Brown,lily - Sayers: Suicide Prevention Services Integration in Coachi $11,544 Yes 0
64.RD Va Ipa Agreement for Alex Burdzy $11,419 Yes 0
64.RD Ipa for Dawei Xie $11,247 Yes 0
64.RD Incorporating Veterans' Preferences Into Lung Cancer Screening Decisio $11,178 Yes 0
64.RD Accelerated Aging As A Cause of Chronic Lung Allograft Dysfunction $11,046 Yes 0
64.RD Ipa - Rebecca Hubbard Ppo 15-143 $9,963 Yes 0
93.853 Extramural Research Programs in the Neurosciences and Neurological Disorders $9,942 Yes 0
43.008 Office of Stem Engagement (ostem) $9,850 Yes 0
64.RD Ipa # 4, Mvp035covid Vujkovic $9,648 Yes 0
84.379 Teacher Education Assistance for College and Higher Education Grants (teach Grants) $9,430 - 0
64.RD Ipa: Shimrit Keddem (project: Cherp) $9,380 Yes 0
93.RD Contraceptive Clinical Trials Network - Female Sites $8,957 Yes 0
64.RD Ipa Agreement for Sofia Lizza $8,536 Yes 0
64.RD Downing Ipa-Top $8,068 Yes 0
81.RD Shape Changing of Responsive Elastomer Structures (scores) $8,039 Yes 0
93.RD Acf Data Governance Consulting and Support Extension Contract $7,878 Yes 0
64.RD Ipa # 3 Damrauer Doe (m. Vujkovic) $7,695 Yes 0
19.022 Educational and Cultural Exchange Programs Appropriation Overseas Grants $7,671 - 0
64.RD Lea Williams Ipa - Va Merit $7,102 Yes 0
93.RD Reverse Transcriptase Inhibition As A Novel Therapeutic Approach for A $6,837 Yes 0
93.226 Covid-19 - Research on Healthcare Costs, Quality and Outcomes $6,524 Yes 0
93.RD Secure Data Management System to Facilitate Prospective Follow Up of P $6,144 Yes 0
64.RD Ipa-Timothy Pond $5,817 Yes 0
93.RD Aids Malignancy Consortium (amc) $5,747 Yes 0
64.U03 Suicide Prevention Programmatic Consultation $5,481 - 0
93.RD Upcc 02717: Optimizing Cord Blood and Haploidentical Aplastic Anemia $5,429 Yes 0
66.203 Environmental Finance Center Grants $5,314 - 0
93.RD Upcc01420: Open-Label, Single-Arm, Multicenter Study, of Combination A $5,000 Yes 0
64.RD The Intra-Individual Changes in Ambulation and Functional Outcomes Amo $4,904 Yes 0
64.RD Developing Personalized Medicine Strategies to Increase Physical Activ $4,799 Yes 0
66.611 Environmental Policy and Innovation Grants $4,375 Yes 0
93.RD Covid-19 - Medical Imaging and Data Resource Center (midrc) for Rapid Response to $4,226 Yes 0
93.394 Covid-19 - Cancer Detection and Diagnosis Research $4,205 Yes 0
64.RD Ipa - Leonard Ppo 15-143 $4,203 Yes 0
12.RD Covid-19 - US Army Combat Capabilities Development Command - Chemical Biological $4,151 Yes 0
98.RD Cultural Change for Transparency Office of the Attorney General of the $4,150 Yes 0
64.U07 Ipa - Laurie Downing $3,894 - 0
64.RD Ipa - Keith Bredemeier $3,605 Yes 0
64.RD Gordon Ipa- Gabriela Khazanov Project $3,433 Yes 0
93.000 Services in Support of the Perinatology Research Branch $2,397 Yes 0
93.342 Lds Dental Outstanding As of 07/01/2021 $2,383 - 0
93.RD Circulating Antibodies to Oral Microbiota and Colon Cancer Risk $2,352 Yes 0
66.511 Office of Research and Development Consolidated Research/training/fellowships $2,201 Yes 0
93.RD Natural History Study of Rubella-Associated Granulomatous Lesions in A $2,175 Yes 0
11.619 Covid-19 - Arrangements for Interdisciplinary Research Infrastructure $2,069 Yes 0
64.RD Traumatic and Treatable Vascular Pathology in the Outcome of Tbi $1,902 Yes 0
64.RD Ipa for Kristin Linn $1,723 Yes 0
64.U02 Cbt-Sp Tele-Hub Project $1,522 - 0
93.RD An Exploration of Barriers and Facilitators to Buprenorphine Access Vi $1,408 Yes 0
64.RD Lynch Ipa - Top $1,219 Yes 0
15.U15 Project Write Online (july 20,2021 - July 30, 2021) $900 - 0
93.RD Mosaico Participant Survey (hvtn 706 Supplement) $731 Yes 0
93.U19 Pennsylvania Higher Education Suicide Prevention Coalition - Welcome B $650 - 0
47.RD Single Wearable Patch for Cost-Effective, Reliable, and Accurate Home $231 Yes 0
12.RD Non-Invasive Monitoring of Traumatic Brain Injury Progression Using Th $186 Yes 0
64.RD Novel Metabolites Associated with Renal Outcomes $21 Yes 0
64.RD Chart Review of the Insomnia Telehealth Program (ipa: James Findley) $-187 Yes 0
81.RD High-Performance Computing Model of Powder-Scale Melting and Solidific $-776 Yes 0
12.RD Sonicviper $-2,440 Yes 0
64.RD Lizbeth Novelo Spire Ipa $-4,333 Yes 0
64.000 Ipa Shimrit Keddem $-8,660 Yes 0
47.078 Polar Programs $-16,812 Yes 0
64.U06 Va/ipa Agreements for Mary Valiga, James Keith and Xiaowang Qu $-34,260 - 0
93.353 Covid-19 - 21st Century Cures Act - Beau Biden Cancer Moonshot $-40,388 Yes 0

Contacts

Name Title Type
GM1XX56LEP58 Susie Won Auditee
2155736706 William Liva Auditor
No contacts on file

Notes to SEFA

Title: Loan/loan guarantee outstanding balances Accounting Policies: The Schedule of Expenditures of Federal Awards (the Schedule) has been prepared to present asummary of those activities of the University of Pennsylvania for the year ended June 30, 2022,which have been financed by the U.S. Government (Federal awards) and is presented on theaccrual basis of accounting. The information in this schedule is presented in accordance with therequirements of Title 2 U.S. Code of Federal Relegations Part 200, Uniform AdministrativeRequirements, Cost Principles, and Audit Requirements for Federal Awards (Uniform Guidance).For purposes of the Schedule, Federal awards include all Federal assistance entered into directlybetween the University of Pennsylvania and the Federal government and sub-awards from non-Federal organizations made under federally sponsored agreements. Because the Schedule presentsonly a selected portion of the activities of the University of Pennsylvania, it is not intended to anddoes not present the financial position or the revenues, expenses or changes in net assets of theUniversity of Pennsylvania.The University applies its predetermined approved facilities and administrative rate when chargingindirect costs to federal awards rather than the 10% de minimis cost rate as described in Section200.414 of the Uniform Guidance.Negative amounts on the schedule represent adjustments in the normal course of business toamounts reported in previous years. Assistance Listing and pass-through award numbers arepresent where available. De Minimis Rate Used: N Rate Explanation: The auditee did not use the de minimis cost rate. PERKINS LOAN OUTSTANDING LOANS ISSUED AS JULY 1, 2021 (84.038) - Balances outstanding at the end of the audit period were 16573964. NURSE FACULTY LOAN PROGRAM OUTSTANDING AS OF 07/01/21 (93.264) - Balances outstanding at the end of the audit period were 2476472. HPL DENTAL OUTSTANDING AS OF 07/01/2021 (93.342) - Balances outstanding at the end of the audit period were 11007366. HPL MEDICAL OUTSTANDING AS OF 07/01/2021 (93.342) - Balances outstanding at the end of the audit period were 133177. HPL VET OUTSTANDING AS OF 07/01/2021 (93.342) - Balances outstanding at the end of the audit period were 3001896. LDS MEDICAL OUTSTANDING AS OF 07/01/2021 (93.342) - Balances outstanding at the end of the audit period were 2385194. NURSING STUDENT LOAN UNDERGRADUATE OUTSTANDING LOANS ISSUED AS OF 07/01/2021 (93.364) - Balances outstanding at the end of the audit period were 3319826. NURSING STUDENT LOAN GRADUATE OUTSTANDING LOANS ISSUED AS OF 07/01/2021 (93.364) - Balances outstanding at the end of the audit period were 522103.

Finding Details

Criteria 2 CFR 200.305 (b3): Reimbursement is the preferred method when the requirements in paragraph (b) cannot be met, when the Federal awarding agency sets a specific condition per ?200.207 Specific conditions, or when the non-Federal entity requests payment by reimbursement. Per the OMB Compliance Supplement, the non-Federal entity must disburse funds for program purposes before requesting payment from the Federal awarding agency or pass-through entity. Condition In testing compliance with the cash management compliance requirement, specifically the reimbursement-method, 40 individual expenditures were tested to compare the date the University made payment to a vendor for a selected expense transaction to the date the University requested sponsor reimbursement for the same transaction. Seven instances were noted in which the University paid the vendor after requesting and receiving reimbursement from the government, as shown in the chart below. See Schedule of Findings and Questioned Costs for chart/table This is a repeat of finding 2021-001, 2020-001, 2019-001, 2018-002 and 2017-002 in prior year audit reports. Cause Management?s current process to ensure that the reimbursement of expenditures occurs only after paying the vendor utilizes the assumption that vendors will be paid within 30 days, on average, of incurring the expense. Effect The University received Federal reimbursement prior to paying the vendors for the selected expenses. The reliance of the 30 day average time-frame allowed certain expenditures to be included in requests for reimbursement prior to being liquidated. Questioned Costs None as reimbursement was requested for allowable costs. Recommendation The University should revisit existing internal control procedures to ensure expenditures are paid in compliance with the Federal reimbursement requirements. We also recommend management discuss current cash management requirements with the OMB and the University?s cognizant agency to determine a solution that meets the needs of both parties. Management?s View and Corrective Action Plan Following these findings are management?s view and corrective action plan.
Criteria Per 2 CFR section 180.220, non-federal entities are prohibited from contracting with or making subawards under covered transactions, where vendor purchases exceed $25,000, to parties that are suspended or debarred. When a non-federal entity enters into a covered transaction, the non-federal entity must verify that the vendor is not suspended or debarred or otherwise excluded from participating in the transaction. This verification may be accomplished by (1) checking the System for Award Management (SAM) Exclusions maintained by the General Services Administration (GSA) and available at SAM.gov, (2) collecting a certification from the Vendor, or (3) adding a clause or condition to the covered transaction with that Vendor. University?s policies mirror the procurement policies as required by the Federal government, and defines a covered transaction as purchases exceeding $10,000. Condition In testing compliance with the suspension and debarment compliance requirement, 1 instance of 25 samples selected for testing was noted where the only evidence available to support the date of the performance of the required suspension and debarment checks was after the transaction date, as shown in the chart below. See Schedule of Findings and Questioned Costs for chart/table Cause The University uses Visual Compliance (VC) for suspension and debarment checks, which was implemented in 2019. Vendors onboarded prior to the implementation were registered and checked via a separate manual process within the procurement department. The above vendor was on-boarded and checked prior to the VC implementation; however, management could not provide evidence that a vendor check was performed prior to conducting business with the vendor due to the manual nature of the legacy process. Management has subsequently performed checks on this vendor and retained documentation of the checks to validate that the vendor is not currently suspended or debarred. Effect If procedures related to vendor suspended and debarred checks are not performed timely, there is a risk that the purchases could be made with a suspended or debarred vendor. Questioned Costs There are no questioned costs associated with this finding. Recommendation We recommend the University further enhance related documentation procedures for evaluating suspended or debarred vendors. Prior to making payments to a vendor, the University should document the review of the vendor to ensure checks are performed timely with proper documentation to evidence the outcome of the vendor review process. Views of responsible officials and planned corrective actions Following this finding is Management?s View and Corrective Action Plan.
Criteria 2 CFR 200.305 (b3): Reimbursement is the preferred method when the requirements in paragraph (b) cannot be met, when the Federal awarding agency sets a specific condition per ?200.207 Specific conditions, or when the non-Federal entity requests payment by reimbursement. Per the OMB Compliance Supplement, the non-Federal entity must disburse funds for program purposes before requesting payment from the Federal awarding agency or pass-through entity. Condition In testing compliance with the cash management compliance requirement, specifically the reimbursement-method, 40 individual expenditures were tested to compare the date the University made payment to a vendor for a selected expense transaction to the date the University requested sponsor reimbursement for the same transaction. Seven instances were noted in which the University paid the vendor after requesting and receiving reimbursement from the government, as shown in the chart below. See Schedule of Findings and Questioned Costs for chart/table This is a repeat of finding 2021-001, 2020-001, 2019-001, 2018-002 and 2017-002 in prior year audit reports. Cause Management?s current process to ensure that the reimbursement of expenditures occurs only after paying the vendor utilizes the assumption that vendors will be paid within 30 days, on average, of incurring the expense. Effect The University received Federal reimbursement prior to paying the vendors for the selected expenses. The reliance of the 30 day average time-frame allowed certain expenditures to be included in requests for reimbursement prior to being liquidated. Questioned Costs None as reimbursement was requested for allowable costs. Recommendation The University should revisit existing internal control procedures to ensure expenditures are paid in compliance with the Federal reimbursement requirements. We also recommend management discuss current cash management requirements with the OMB and the University?s cognizant agency to determine a solution that meets the needs of both parties. Management?s View and Corrective Action Plan Following these findings are management?s view and corrective action plan.
Criteria 2 CFR 200.305 (b3): Reimbursement is the preferred method when the requirements in paragraph (b) cannot be met, when the Federal awarding agency sets a specific condition per ?200.207 Specific conditions, or when the non-Federal entity requests payment by reimbursement. Per the OMB Compliance Supplement, the non-Federal entity must disburse funds for program purposes before requesting payment from the Federal awarding agency or pass-through entity. Condition In testing compliance with the cash management compliance requirement, specifically the reimbursement-method, 40 individual expenditures were tested to compare the date the University made payment to a vendor for a selected expense transaction to the date the University requested sponsor reimbursement for the same transaction. Seven instances were noted in which the University paid the vendor after requesting and receiving reimbursement from the government, as shown in the chart below. See Schedule of Findings and Questioned Costs for chart/table This is a repeat of finding 2021-001, 2020-001, 2019-001, 2018-002 and 2017-002 in prior year audit reports. Cause Management?s current process to ensure that the reimbursement of expenditures occurs only after paying the vendor utilizes the assumption that vendors will be paid within 30 days, on average, of incurring the expense. Effect The University received Federal reimbursement prior to paying the vendors for the selected expenses. The reliance of the 30 day average time-frame allowed certain expenditures to be included in requests for reimbursement prior to being liquidated. Questioned Costs None as reimbursement was requested for allowable costs. Recommendation The University should revisit existing internal control procedures to ensure expenditures are paid in compliance with the Federal reimbursement requirements. We also recommend management discuss current cash management requirements with the OMB and the University?s cognizant agency to determine a solution that meets the needs of both parties. Management?s View and Corrective Action Plan Following these findings are management?s view and corrective action plan.
Criteria 2 CFR 200.305 (b3): Reimbursement is the preferred method when the requirements in paragraph (b) cannot be met, when the Federal awarding agency sets a specific condition per ?200.207 Specific conditions, or when the non-Federal entity requests payment by reimbursement. Per the OMB Compliance Supplement, the non-Federal entity must disburse funds for program purposes before requesting payment from the Federal awarding agency or pass-through entity. Condition In testing compliance with the cash management compliance requirement, specifically the reimbursement-method, 40 individual expenditures were tested to compare the date the University made payment to a vendor for a selected expense transaction to the date the University requested sponsor reimbursement for the same transaction. Seven instances were noted in which the University paid the vendor after requesting and receiving reimbursement from the government, as shown in the chart below. See Schedule of Findings and Questioned Costs for chart/table This is a repeat of finding 2021-001, 2020-001, 2019-001, 2018-002 and 2017-002 in prior year audit reports. Cause Management?s current process to ensure that the reimbursement of expenditures occurs only after paying the vendor utilizes the assumption that vendors will be paid within 30 days, on average, of incurring the expense. Effect The University received Federal reimbursement prior to paying the vendors for the selected expenses. The reliance of the 30 day average time-frame allowed certain expenditures to be included in requests for reimbursement prior to being liquidated. Questioned Costs None as reimbursement was requested for allowable costs. Recommendation The University should revisit existing internal control procedures to ensure expenditures are paid in compliance with the Federal reimbursement requirements. We also recommend management discuss current cash management requirements with the OMB and the University?s cognizant agency to determine a solution that meets the needs of both parties. Management?s View and Corrective Action Plan Following these findings are management?s view and corrective action plan.
Criteria 2 CFR 200.305 (b3): Reimbursement is the preferred method when the requirements in paragraph (b) cannot be met, when the Federal awarding agency sets a specific condition per ?200.207 Specific conditions, or when the non-Federal entity requests payment by reimbursement. Per the OMB Compliance Supplement, the non-Federal entity must disburse funds for program purposes before requesting payment from the Federal awarding agency or pass-through entity. Condition In testing compliance with the cash management compliance requirement, specifically the reimbursement-method, 40 individual expenditures were tested to compare the date the University made payment to a vendor for a selected expense transaction to the date the University requested sponsor reimbursement for the same transaction. Seven instances were noted in which the University paid the vendor after requesting and receiving reimbursement from the government, as shown in the chart below. See Schedule of Findings and Questioned Costs for chart/table This is a repeat of finding 2021-001, 2020-001, 2019-001, 2018-002 and 2017-002 in prior year audit reports. Cause Management?s current process to ensure that the reimbursement of expenditures occurs only after paying the vendor utilizes the assumption that vendors will be paid within 30 days, on average, of incurring the expense. Effect The University received Federal reimbursement prior to paying the vendors for the selected expenses. The reliance of the 30 day average time-frame allowed certain expenditures to be included in requests for reimbursement prior to being liquidated. Questioned Costs None as reimbursement was requested for allowable costs. Recommendation The University should revisit existing internal control procedures to ensure expenditures are paid in compliance with the Federal reimbursement requirements. We also recommend management discuss current cash management requirements with the OMB and the University?s cognizant agency to determine a solution that meets the needs of both parties. Management?s View and Corrective Action Plan Following these findings are management?s view and corrective action plan.
Criteria 2 CFR 200.305 (b3): Reimbursement is the preferred method when the requirements in paragraph (b) cannot be met, when the Federal awarding agency sets a specific condition per ?200.207 Specific conditions, or when the non-Federal entity requests payment by reimbursement. Per the OMB Compliance Supplement, the non-Federal entity must disburse funds for program purposes before requesting payment from the Federal awarding agency or pass-through entity. Condition In testing compliance with the cash management compliance requirement, specifically the reimbursement-method, 40 individual expenditures were tested to compare the date the University made payment to a vendor for a selected expense transaction to the date the University requested sponsor reimbursement for the same transaction. Seven instances were noted in which the University paid the vendor after requesting and receiving reimbursement from the government, as shown in the chart below. See Schedule of Findings and Questioned Costs for chart/table This is a repeat of finding 2021-001, 2020-001, 2019-001, 2018-002 and 2017-002 in prior year audit reports. Cause Management?s current process to ensure that the reimbursement of expenditures occurs only after paying the vendor utilizes the assumption that vendors will be paid within 30 days, on average, of incurring the expense. Effect The University received Federal reimbursement prior to paying the vendors for the selected expenses. The reliance of the 30 day average time-frame allowed certain expenditures to be included in requests for reimbursement prior to being liquidated. Questioned Costs None as reimbursement was requested for allowable costs. Recommendation The University should revisit existing internal control procedures to ensure expenditures are paid in compliance with the Federal reimbursement requirements. We also recommend management discuss current cash management requirements with the OMB and the University?s cognizant agency to determine a solution that meets the needs of both parties. Management?s View and Corrective Action Plan Following these findings are management?s view and corrective action plan.
Criteria 2 CFR 200.305 (b3): Reimbursement is the preferred method when the requirements in paragraph (b) cannot be met, when the Federal awarding agency sets a specific condition per ?200.207 Specific conditions, or when the non-Federal entity requests payment by reimbursement. Per the OMB Compliance Supplement, the non-Federal entity must disburse funds for program purposes before requesting payment from the Federal awarding agency or pass-through entity. Condition In testing compliance with the cash management compliance requirement, specifically the reimbursement-method, 40 individual expenditures were tested to compare the date the University made payment to a vendor for a selected expense transaction to the date the University requested sponsor reimbursement for the same transaction. Seven instances were noted in which the University paid the vendor after requesting and receiving reimbursement from the government, as shown in the chart below. See Schedule of Findings and Questioned Costs for chart/table This is a repeat of finding 2021-001, 2020-001, 2019-001, 2018-002 and 2017-002 in prior year audit reports. Cause Management?s current process to ensure that the reimbursement of expenditures occurs only after paying the vendor utilizes the assumption that vendors will be paid within 30 days, on average, of incurring the expense. Effect The University received Federal reimbursement prior to paying the vendors for the selected expenses. The reliance of the 30 day average time-frame allowed certain expenditures to be included in requests for reimbursement prior to being liquidated. Questioned Costs None as reimbursement was requested for allowable costs. Recommendation The University should revisit existing internal control procedures to ensure expenditures are paid in compliance with the Federal reimbursement requirements. We also recommend management discuss current cash management requirements with the OMB and the University?s cognizant agency to determine a solution that meets the needs of both parties. Management?s View and Corrective Action Plan Following these findings are management?s view and corrective action plan.
Criteria Per 2 CFR section 180.220, non-federal entities are prohibited from contracting with or making subawards under covered transactions, where vendor purchases exceed $25,000, to parties that are suspended or debarred. When a non-federal entity enters into a covered transaction, the non-federal entity must verify that the vendor is not suspended or debarred or otherwise excluded from participating in the transaction. This verification may be accomplished by (1) checking the System for Award Management (SAM) Exclusions maintained by the General Services Administration (GSA) and available at SAM.gov, (2) collecting a certification from the Vendor, or (3) adding a clause or condition to the covered transaction with that Vendor. University?s policies mirror the procurement policies as required by the Federal government, and defines a covered transaction as purchases exceeding $10,000. Condition In testing compliance with the suspension and debarment compliance requirement, 1 instance of 25 samples selected for testing was noted where the only evidence available to support the date of the performance of the required suspension and debarment checks was after the transaction date, as shown in the chart below. See Schedule of Findings and Questioned Costs for chart/table Cause The University uses Visual Compliance (VC) for suspension and debarment checks, which was implemented in 2019. Vendors onboarded prior to the implementation were registered and checked via a separate manual process within the procurement department. The above vendor was on-boarded and checked prior to the VC implementation; however, management could not provide evidence that a vendor check was performed prior to conducting business with the vendor due to the manual nature of the legacy process. Management has subsequently performed checks on this vendor and retained documentation of the checks to validate that the vendor is not currently suspended or debarred. Effect If procedures related to vendor suspended and debarred checks are not performed timely, there is a risk that the purchases could be made with a suspended or debarred vendor. Questioned Costs There are no questioned costs associated with this finding. Recommendation We recommend the University further enhance related documentation procedures for evaluating suspended or debarred vendors. Prior to making payments to a vendor, the University should document the review of the vendor to ensure checks are performed timely with proper documentation to evidence the outcome of the vendor review process. Views of responsible officials and planned corrective actions Following this finding is Management?s View and Corrective Action Plan.
Criteria 2 CFR 200.305 (b3): Reimbursement is the preferred method when the requirements in paragraph (b) cannot be met, when the Federal awarding agency sets a specific condition per ?200.207 Specific conditions, or when the non-Federal entity requests payment by reimbursement. Per the OMB Compliance Supplement, the non-Federal entity must disburse funds for program purposes before requesting payment from the Federal awarding agency or pass-through entity. Condition In testing compliance with the cash management compliance requirement, specifically the reimbursement-method, 40 individual expenditures were tested to compare the date the University made payment to a vendor for a selected expense transaction to the date the University requested sponsor reimbursement for the same transaction. Seven instances were noted in which the University paid the vendor after requesting and receiving reimbursement from the government, as shown in the chart below. See Schedule of Findings and Questioned Costs for chart/table This is a repeat of finding 2021-001, 2020-001, 2019-001, 2018-002 and 2017-002 in prior year audit reports. Cause Management?s current process to ensure that the reimbursement of expenditures occurs only after paying the vendor utilizes the assumption that vendors will be paid within 30 days, on average, of incurring the expense. Effect The University received Federal reimbursement prior to paying the vendors for the selected expenses. The reliance of the 30 day average time-frame allowed certain expenditures to be included in requests for reimbursement prior to being liquidated. Questioned Costs None as reimbursement was requested for allowable costs. Recommendation The University should revisit existing internal control procedures to ensure expenditures are paid in compliance with the Federal reimbursement requirements. We also recommend management discuss current cash management requirements with the OMB and the University?s cognizant agency to determine a solution that meets the needs of both parties. Management?s View and Corrective Action Plan Following these findings are management?s view and corrective action plan.
Criteria 2 CFR 200.305 (b3): Reimbursement is the preferred method when the requirements in paragraph (b) cannot be met, when the Federal awarding agency sets a specific condition per ?200.207 Specific conditions, or when the non-Federal entity requests payment by reimbursement. Per the OMB Compliance Supplement, the non-Federal entity must disburse funds for program purposes before requesting payment from the Federal awarding agency or pass-through entity. Condition In testing compliance with the cash management compliance requirement, specifically the reimbursement-method, 40 individual expenditures were tested to compare the date the University made payment to a vendor for a selected expense transaction to the date the University requested sponsor reimbursement for the same transaction. Seven instances were noted in which the University paid the vendor after requesting and receiving reimbursement from the government, as shown in the chart below. See Schedule of Findings and Questioned Costs for chart/table This is a repeat of finding 2021-001, 2020-001, 2019-001, 2018-002 and 2017-002 in prior year audit reports. Cause Management?s current process to ensure that the reimbursement of expenditures occurs only after paying the vendor utilizes the assumption that vendors will be paid within 30 days, on average, of incurring the expense. Effect The University received Federal reimbursement prior to paying the vendors for the selected expenses. The reliance of the 30 day average time-frame allowed certain expenditures to be included in requests for reimbursement prior to being liquidated. Questioned Costs None as reimbursement was requested for allowable costs. Recommendation The University should revisit existing internal control procedures to ensure expenditures are paid in compliance with the Federal reimbursement requirements. We also recommend management discuss current cash management requirements with the OMB and the University?s cognizant agency to determine a solution that meets the needs of both parties. Management?s View and Corrective Action Plan Following these findings are management?s view and corrective action plan.
Criteria 2 CFR 200.305 (b3): Reimbursement is the preferred method when the requirements in paragraph (b) cannot be met, when the Federal awarding agency sets a specific condition per ?200.207 Specific conditions, or when the non-Federal entity requests payment by reimbursement. Per the OMB Compliance Supplement, the non-Federal entity must disburse funds for program purposes before requesting payment from the Federal awarding agency or pass-through entity. Condition In testing compliance with the cash management compliance requirement, specifically the reimbursement-method, 40 individual expenditures were tested to compare the date the University made payment to a vendor for a selected expense transaction to the date the University requested sponsor reimbursement for the same transaction. Seven instances were noted in which the University paid the vendor after requesting and receiving reimbursement from the government, as shown in the chart below. See Schedule of Findings and Questioned Costs for chart/table This is a repeat of finding 2021-001, 2020-001, 2019-001, 2018-002 and 2017-002 in prior year audit reports. Cause Management?s current process to ensure that the reimbursement of expenditures occurs only after paying the vendor utilizes the assumption that vendors will be paid within 30 days, on average, of incurring the expense. Effect The University received Federal reimbursement prior to paying the vendors for the selected expenses. The reliance of the 30 day average time-frame allowed certain expenditures to be included in requests for reimbursement prior to being liquidated. Questioned Costs None as reimbursement was requested for allowable costs. Recommendation The University should revisit existing internal control procedures to ensure expenditures are paid in compliance with the Federal reimbursement requirements. We also recommend management discuss current cash management requirements with the OMB and the University?s cognizant agency to determine a solution that meets the needs of both parties. Management?s View and Corrective Action Plan Following these findings are management?s view and corrective action plan.
Criteria 2 CFR 200.305 (b3): Reimbursement is the preferred method when the requirements in paragraph (b) cannot be met, when the Federal awarding agency sets a specific condition per ?200.207 Specific conditions, or when the non-Federal entity requests payment by reimbursement. Per the OMB Compliance Supplement, the non-Federal entity must disburse funds for program purposes before requesting payment from the Federal awarding agency or pass-through entity. Condition In testing compliance with the cash management compliance requirement, specifically the reimbursement-method, 40 individual expenditures were tested to compare the date the University made payment to a vendor for a selected expense transaction to the date the University requested sponsor reimbursement for the same transaction. Seven instances were noted in which the University paid the vendor after requesting and receiving reimbursement from the government, as shown in the chart below. See Schedule of Findings and Questioned Costs for chart/table This is a repeat of finding 2021-001, 2020-001, 2019-001, 2018-002 and 2017-002 in prior year audit reports. Cause Management?s current process to ensure that the reimbursement of expenditures occurs only after paying the vendor utilizes the assumption that vendors will be paid within 30 days, on average, of incurring the expense. Effect The University received Federal reimbursement prior to paying the vendors for the selected expenses. The reliance of the 30 day average time-frame allowed certain expenditures to be included in requests for reimbursement prior to being liquidated. Questioned Costs None as reimbursement was requested for allowable costs. Recommendation The University should revisit existing internal control procedures to ensure expenditures are paid in compliance with the Federal reimbursement requirements. We also recommend management discuss current cash management requirements with the OMB and the University?s cognizant agency to determine a solution that meets the needs of both parties. Management?s View and Corrective Action Plan Following these findings are management?s view and corrective action plan.
Criteria 2 CFR 200.305 (b3): Reimbursement is the preferred method when the requirements in paragraph (b) cannot be met, when the Federal awarding agency sets a specific condition per ?200.207 Specific conditions, or when the non-Federal entity requests payment by reimbursement. Per the OMB Compliance Supplement, the non-Federal entity must disburse funds for program purposes before requesting payment from the Federal awarding agency or pass-through entity. Condition In testing compliance with the cash management compliance requirement, specifically the reimbursement-method, 40 individual expenditures were tested to compare the date the University made payment to a vendor for a selected expense transaction to the date the University requested sponsor reimbursement for the same transaction. Seven instances were noted in which the University paid the vendor after requesting and receiving reimbursement from the government, as shown in the chart below. See Schedule of Findings and Questioned Costs for chart/table This is a repeat of finding 2021-001, 2020-001, 2019-001, 2018-002 and 2017-002 in prior year audit reports. Cause Management?s current process to ensure that the reimbursement of expenditures occurs only after paying the vendor utilizes the assumption that vendors will be paid within 30 days, on average, of incurring the expense. Effect The University received Federal reimbursement prior to paying the vendors for the selected expenses. The reliance of the 30 day average time-frame allowed certain expenditures to be included in requests for reimbursement prior to being liquidated. Questioned Costs None as reimbursement was requested for allowable costs. Recommendation The University should revisit existing internal control procedures to ensure expenditures are paid in compliance with the Federal reimbursement requirements. We also recommend management discuss current cash management requirements with the OMB and the University?s cognizant agency to determine a solution that meets the needs of both parties. Management?s View and Corrective Action Plan Following these findings are management?s view and corrective action plan.